Comment
doi: 10.1056/NEJMc1301594.
Abiraterone in metastatic prostate cancer
- PMID: 23574135
- DOI: 10.1056/NEJMc1301594
Item in Clipboard
Comment
Abiraterone in metastatic prostate cancer
N Engl J Med.
.
No abstract available
Comment in
-
Abiraterone in metastatic prostate cancer.N Engl J Med. 2013 Apr 11;368(15):1458-9. doi: 10.1056/NEJMc1301594. N Engl J Med. 2013. PMID: 23574133 No abstract available.
Comment on
-
Abiraterone in metastatic prostate cancer without previous chemotherapy.N Engl J Med. 2013 Jan 10;368(2):138-48. doi: 10.1056/NEJMoa1209096. Epub 2012 Dec 10. N Engl J Med. 2013. PMID: 23228172 Free PMC article. Clinical Trial.
Similar articles
-
Abiraterone in metastatic prostate cancer.N Engl J Med. 2013 Apr 11;368(15):1457. doi: 10.1056/NEJMc1301594. N Engl J Med. 2013. PMID: 23574134 No abstract available.
-
Abiraterone in metastatic prostate cancer.N Engl J Med. 2013 Apr 11;368(15):1458-9. doi: 10.1056/NEJMc1301594. N Engl J Med. 2013. PMID: 23574133 No abstract available.
-
Re: Abiraterone in metastatic prostate cancer without previous chemotherapy.J Urol. 2013 Sep;190(3):880. doi: 10.1016/j.juro.2013.05.104. Epub 2013 Jun 7. J Urol. 2013. PMID: 23931193 No abstract available.
-
[Abiraterone acetate (AA): current guidelines of prescription of abiraterone].Bull Cancer. 2014 Apr;101(4):388-93. doi: 10.1684/bdc.2014.1932. Bull Cancer. 2014. PMID: 24793632 Review. French.
-
Development and clinical utility of abiraterone acetate as an androgen synthesis inhibitor.Clin Pharmacol Ther. 2012 Jan;91(1):101-8. doi: 10.1038/clpt.2011.275. Epub 2011 Nov 30. Clin Pharmacol Ther. 2012. PMID: 22130117 Review.
Cited by
-
PI-3 kinase p110β: a therapeutic target in advanced prostate cancers.Am J Clin Exp Urol. 2014 Oct 2;2(3):188-98. eCollection 2014. Am J Clin Exp Urol. 2014. PMID: 25374921 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
